178 related articles for article (PubMed ID: 26790469)
1. Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study.
Kwon TJ; Tantry US; Park Y; Choi YM; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Smith SC; Jeong YH
Thromb Haemost; 2016 May; 115(5):979-92. PubMed ID: 26790469
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
[TBL] [Abstract][Full Text] [Related]
3. Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry.
Danese E; Fava C; Beltrame F; Tavella D; Calabria S; Benati M; Gelati M; Gottardo R; Tagliaro F; Guidi GC; Cattaneo M; Minuz P
J Thromb Haemost; 2016 Feb; 14(2):282-93. PubMed ID: 26576037
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA
Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660
[TBL] [Abstract][Full Text] [Related]
5. Platelet turnover predicts outcome after coronary intervention.
Freynhofer MK; Iliev L; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Huber K
Thromb Haemost; 2017 May; 117(5):923-933. PubMed ID: 28229159
[TBL] [Abstract][Full Text] [Related]
6. Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading.
Kim IS; Jeong YH; Tantry US; Park Y; Lee DH; Bliden KP; Koh JS; Park JR; Jang JS; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S; Gurbel PA
Am Heart J; 2013 Jul; 166(1):95-103. PubMed ID: 23816027
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the efficacy of ADP inhibitor treatment in patients with acute STEMI post-PCI by VASP-P flow cytometry assay.
Fedor M; Samoš M; Šimonová R; Fedorová J; Škorňová I; Duraj L; Staško J; Kovář F; Mokáň M; Kubisz P
Clin Appl Thromb Hemost; 2015 May; 21(4):334-8. PubMed ID: 24989714
[TBL] [Abstract][Full Text] [Related]
9. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
[TBL] [Abstract][Full Text] [Related]
10. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
[TBL] [Abstract][Full Text] [Related]
11. Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Laine M; Panagides V; Frère C; Cuisset T; Gouarne C; Jouve B; Thuny F; Paganelli F; Alessi MC; Mancini J; Bonello L
J Thromb Haemost; 2019 Dec; 17(12):2188-2195. PubMed ID: 31351022
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study.
Hu C; Zhang X; Liu Y; Gao Y; Zhao X; Zhou H; Luo Y; Liu Y; Wang X
BMC Cardiovasc Disord; 2018 Jun; 18(1):120. PubMed ID: 29914380
[TBL] [Abstract][Full Text] [Related]
13. Relationship between CYP2C19 loss-of-function polymorphism and platelet reactivities with clopidogrel treatment in Japanese patients undergoing coronary stent implantation.
Nakata T; Miyahara M; Nakatani K; Wada H; Tanigawa T; Komada F; Hoshino K; Aoki T; Nishimura Y; Tamaru S; Ito M; Nishikawa M;
Circ J; 2013; 77(6):1436-44. PubMed ID: 23470885
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
15. Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China.
Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
Eur J Clin Pharmacol; 2022 Feb; 78(2):215-225. PubMed ID: 34636928
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism.
Bonello L; Armero S; Ait Mokhtar O; Mancini J; Aldebert P; Saut N; Bonello N; Barragan P; Arques S; Giacomoni MP; Bonello-Burignat C; Bartholomei MN; Dignat-George F; Camoin-Jau L; Paganelli F
J Am Coll Cardiol; 2010 Nov; 56(20):1630-6. PubMed ID: 20708365
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
[TBL] [Abstract][Full Text] [Related]
18. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
Gajos G; Rostoff P; Undas A; Piwowarska W
J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.
Novkovic M; Matic D; Kusic-Tisma J; Antonijevic N; Radojkovic D; Rakicevic L
Eur J Clin Pharmacol; 2018 Apr; 74(4):443-451. PubMed ID: 29260275
[TBL] [Abstract][Full Text] [Related]
20. Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.
Gaglia MA; Torguson R; Pokharel S; Pakala R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(2):76-80. PubMed ID: 23375617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]